BTIG Research Reaffirms “Buy” Rating for GE HealthCare Technologies (NASDAQ:GEHC)

GE HealthCare Technologies (NASDAQ:GEHC)‘s stock had its “buy” rating restated by investment analysts at BTIG Research in a report released on Thursday,Benzinga reports. They currently have a $91.00 target price on the stock. BTIG Research’s price target would indicate a potential upside of 30.74% from the company’s previous close.

Other equities research analysts also recently issued research reports about the stock. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Citigroup dropped their price target on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 11th. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Bank of America upped their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Finally, Stifel Nicolaus increased their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $92.17.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $69.61 on Thursday. The firm’s 50-day moving average price is $79.22 and its 200-day moving average price is $78.38. GE HealthCare Technologies has a 52-week low of $57.65 and a 52-week high of $89.77. The company has a market cap of $31.72 billion, a PE ratio of 15.26, a PEG ratio of 1.55 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of hedge funds have recently made changes to their positions in GEHC. E Fund Management Hong Kong Co. Ltd. increased its stake in GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after acquiring an additional 196 shares during the last quarter. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at approximately $26,000. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $26,000. Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $27,000. Finally, Godfrey Financial Associates Inc. bought a new stake in GE HealthCare Technologies in the fourth quarter worth $27,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.